Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2012
06/28/2012US20120164158 Anti-ADDL Monoclonal Antibody and Use Thereof
06/28/2012US20120164157 Method of treating stroke with thrombolytic agent
06/28/2012US20120164152 Anti-il-17f antibodies and methods of use thereof
06/28/2012US20120164139 Dopamine 3 receptor agonist and antagonist treatment of gastrointestinal motility disorders
06/28/2012US20120164138 Use of anti-cd1 antibodies for the modulation of immune responses
06/28/2012US20120164128 Means and methods for counteracting polyq expansion disorders
06/28/2012US20120164122 Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases
06/28/2012US20120164114 Treatment of immune-related diseases and disorders using amnion derived adherent cells
06/28/2012US20120164113 Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
06/28/2012US20120164108 Virus strains
06/28/2012US20120164078 Methods of using sustained release aminopyridine compositions
06/28/2012US20120164077 Predictive assays for cell transplantation efficacy and methods of using human neuropotentiating cells
06/28/2012US20120164075 Endoxifen methods and compositions in the treatment of mammalian diseases
06/28/2012US20120164072 Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
06/28/2012US20120164070 Benzothiazole and benzooxazole derivatives and methods of use
06/28/2012US20120164067 Methods of preventing or treating pain using anti-ngf antibodies that selectively inhibit the association of ngf with trka, without affecting the association of ngf with p75
06/28/2012DE102010063974A1 Preparing a radioactive fluorine substituted (1,2,4)oxadiazole compound, useful as radiodiagnostic to diagonize e.g. neurological and psychiatric disorders, comprises reacting a (1,2,4)oxadiazole compound with a radioactive fluorine
06/28/2012CA2845524A1 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
06/28/2012CA2822842A1 Faah inhibitors
06/28/2012CA2822789A1 Substituted pyridines as sodium channel blockers
06/28/2012CA2822553A1 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
06/28/2012CA2822453A1 Novel morphinans useful as analgesics
06/28/2012CA2822378A1 Compounds and their use as bace inhibitors
06/28/2012CA2821480A1 2-carboxamide-4-piperazinyl-benzofuran derivative
06/28/2012CA2821315A1 Novel multicomponent crystals made of ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and an arylpropionic acid
06/28/2012CA2821311A1 Novel multicomponent crystals made of ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and 2-[2-[(2,6-dichlorophenyl)-amino]-phenyl] acetic acid
06/28/2012CA2819961A1 Novel fused pyridine compounds as casein kinase inhibitors
06/28/2012CA2819175A1 5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (bace)
06/27/2012EP2468770A1 Humanized antibody against amyloid beta
06/27/2012EP2468732A1 1H-Quinazoline-2,4-diones
06/27/2012EP2468728A1 2-(1-phenyl-4,5,6,7-tetrahydro-1H-indazol-4-YL)ethylamine derivatives useful as sigma receptor inhibitors
06/27/2012EP2468279A1 Prokineticin 1 receptor agonists and their uses
06/27/2012EP2468273A2 Method to reduce oxidative damage and improve mitochondrial efficiency
06/27/2012EP2468272A1 Methods of treating a neurological disorder with creatine monohydrate
06/27/2012EP2468271A1 Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia
06/27/2012EP2468261A1 Formulation of lacosamide
06/27/2012EP2468253A1 Terpenoid spiro ketal compounds with LXR agonists activity, their use and formulations with them
06/27/2012EP2467482A2 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip
06/27/2012EP2467398A1 Trp inhibitors and uses thereof
06/27/2012EP2467385A1 Renin inhibitors
06/27/2012EP2467382A1 Amino tetrahydro-pyridopyrimidine pde10 inhibitors
06/27/2012EP2467372A1 Treatment of bdnf-related disorders using laquinimod
06/27/2012EP2467153A1 Use of mimotopes of alpha-synuclein epitopes for treating lewy body diseases
06/27/2012EP2467136A1 4-methylpyrazole formulations
06/27/2012EP2326328B1 Use of dihydralazine for the treatment of diseases related to elevated semicarbazide sensitive amine-oxidase (ssao) activity
06/27/2012EP2188263B1 Benzimidazole derivatives used as fxr agonists
06/27/2012EP2185553B1 Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
06/27/2012EP2123628B1 A process for preparing optical pure milnacipran and its pharmaceutically accepted salts
06/27/2012EP2120985B1 FN-38 peptides for use in the treatment of psychotic and anxiety disorders
06/27/2012EP2097079B1 Modulation of prostaglandin/cyclooxygenase metabolic pathways
06/27/2012EP2009992B1 Il-8 receptor antagonists
06/27/2012EP1999120B1 Benzothiazoles having histamine h3 receptor activity
06/27/2012EP1868600B1 Spirocyclic cyclohexane derivatives for use in the treatment of substance dependency
06/27/2012EP1841464B1 Rnai modulation of the nogo-l or nogo-r gene and uses thereof
06/27/2012EP1751087B1 Levodopa derivatives, and compositions and uses thereof
06/27/2012EP1719762B1 Novel pyridine derivative and pyrimidine derivative (1)
06/27/2012EP1698624B1 Phenylpropanoic acid derivatives
06/27/2012EP1626958B1 (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht 1f agonists
06/27/2012CN1903243B Guhong control-release tablets and prepn. method therefor
06/27/2012CN1882587B Use of tricyclic compounds as glycine transport inhibitors
06/27/2012CN1826323B 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
06/27/2012CN1816524B Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
06/27/2012CN1678304B PKC activation as a means for enhancing aAPP-a secretion and improving cognition using bryostatin type compounds
06/27/2012CN1665828B Novel substituted sulfamate anticonvulsant derivatives
06/27/2012CN102516360A Polypeptide capable of inhibiting beta-secretase digestion effect and application thereof
06/27/2012CN102516359A Novel anti-senile dementia lead compound
06/27/2012CN102516357A Polypeptide combined with A-beta amyloid and application thereof
06/27/2012CN102516352A Smilagenin in crystalline and amorphous forms
06/27/2012CN102516297A Pyritinol hydrochloride derivative for treatment and purpose thereof
06/27/2012CN102516247A A-type calcium L-5-methyltetrahydrofolate polymorphism and preparation method thereof
06/27/2012CN102516241A CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives
06/27/2012CN102516211A Process for production of optically active amine derivatives
06/27/2012CN102516200A Hybrid compound with indanone and phenothiazine as skeletal structures and application thereof
06/27/2012CN102516192A Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
06/27/2012CN102516176A Indazole derivatives that inhibit TRPVL receptor
06/27/2012CN102516165A Substituted pyridine derivatives
06/27/2012CN102516161A Pyridine and pyrimidine derivatives as mglur2 antagonists
06/27/2012CN102516115A Novel compounds as antagonists or inverse agonists at opioid receptors
06/27/2012CN102516107A N-benzylaniline derivatives and application thereof
06/27/2012CN102512675A Method for treating multiple sclerosis
06/27/2012CN102512664A Nerve growth factor composition
06/27/2012CN102512650A Externally-used medicine for treating facial paralysis
06/27/2012CN102512636A Chinese medicinal herb for treating tristimania and preparation method thereof
06/27/2012CN102512634A Compound musk soft capsule and preparing method thereof
06/27/2012CN102512633A Traditional Chinese medicinal composition for treating insomnia
06/27/2012CN102512619A Traditional Chinese medicine composition used for treating headache
06/27/2012CN102512578A Dripping core pill preparation with effect of relieving sore throat and preparation method thereof
06/27/2012CN102512576A Asparagus tuber vacuum freeze-drying processing method
06/27/2012CN102512529A Traditional Chinese medicinal patch for treating infantile night cry
06/27/2012CN102512527A Traditional Chinese medicine composite for treating post-stroke depression
06/27/2012CN102512521A Traditional Chinese medicine composition for treating apoplexy sequela
06/27/2012CN102512518A Chinese medicinal extract for treating diabetic peripheral neuropathy and preparation method thereof
06/27/2012CN102512513A Formula used for treating insomnia
06/27/2012CN102512508A Application of rheum emodi wall extract to preparation of medicines for resisting ischemic cerebral vascular diseases
06/27/2012CN102512497A Extracting method for active ingredients of red-rooted salvia root medicinal material
06/27/2012CN102512475A Method for extracting total alkaloids from common nandina
06/27/2012CN102512450A Preparation method for donkey-hide gelatin pills
06/27/2012CN102512444A Preparation method for mongolian medicine vermilion nanometer powder
06/27/2012CN102512435A Application of 5,6,4'-trihydroxyl flavone-7-O-beta-D-glucuronide methyl ester and medicinal composition as well as preparation thereof
06/27/2012CN102512422A Composition and method for enhanced delivery of 5,5-diphenyl barbituric acid
1 ... 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 ... 1833